Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
9.58
-0.19 (-1.94%)
At close: Mar 11, 2026, 4:00 PM EDT
9.58
0.00 (0.00%)
After-hours: Mar 11, 2026, 5:43 PM EDT
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $515.72 million as of March 11, 2026. Its market cap has decreased by -37.07% in one year.
Market Cap
515.72M
Enterprise Value
216.56M
1-Year Change
-37.07%
Ranking
Category
Stock Price
$9.58
Market Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $515.72M, an increase of 305.12%. That is a compound annual growth rate of 11.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 525.90M | 2.30% |
| Dec 31, 2025 | 514.10M | -31.02% |
| Dec 31, 2024 | 745.30M | -61.78% |
| Dec 29, 2023 | 1.95B | -33.09% |
| Dec 30, 2022 | 2.91B | 26.63% |
| Dec 31, 2021 | 2.30B | 380.02% |
| Dec 31, 2020 | 479.50M | -24.08% |
| Dec 31, 2019 | 631.60M | 53.82% |
| Dec 31, 2018 | 410.60M | -71.51% |
| Dec 29, 2017 | 1.44B | -15.04% |
| Dec 30, 2016 | 1.70B | -20.98% |
| Dec 31, 2015 | 2.15B | 277.66% |
| Dec 31, 2014 | 568.50M | -1.92% |
| Dec 31, 2013 | 579.60M | 347.22% |
| Dec 31, 2012 | 129.60M | 1.81% |
| Dec 21, 2012 | 127.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 548.03M |
| YD Bio | 544.98M |
| Lyell Immunopharma | 544.48M |
| Fulcrum Therapeutics | 533.47M |
| CorMedix | 531.22M |
| Kyverna Therapeutics | 527.31M |
| Lexeo Therapeutics | 525.51M |
| Rigel Pharmaceuticals | 525.38M |